Copyright © 2015 - 2022 Lifecarenews.in
LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
Balaxi Pharmaceuticals Growth Remains Robust on Back of Geographical Expansions
Revenue growth of 40.3% on YoY basis, with operating EBITDA of Rs. 15.29 crore
PAT stood at Rs. 8.23 crore
Revenue from Pharmaceutical business grew by 40.4%…